Personalis Inc (PSNL)
Healthcare
Diagnostics & Research
13.50 $
+2.4%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
| Tick rows to compare them in a chart (up to 4) | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +111.3% | +32.4% | +12.9% | +7.0% | +12.4% | +8.4% | +5.8% | +5.5% | +1.7% | +1.6% | +1.8% | +3.5% | +3.8% | +2.7% | -7.1% | -26.4% | +19.8% | -18.5% | +12.5% | +12.8% | -11.5% | +9.3% | +7.8% | -0.8% | +15.6% | +13.9% | -34.7% | +22.6% | -16.5% | -15.7% | +19.7% | -10.8% | – | |
| – | +57.5% | +12.0% | +16.1% | +21.2% | -1.7% | +16.1% | +0.6% | +30.5% | -2.0% | -2.3% | -2.6% | -4.6% | +0.4% | +5.1% | -10.6% | -13.7% | +27.5% | -11.3% | +16.4% | -1.9% | -15.7% | +24.0% | -2.0% | -3.0% | +3.6% | +16.6% | -27.8% | +9.4% | -7.1% | +1.1% | +22.8% | -1.7% | – | |
| – | +2,320.2% | +87.0% | +7.8% | -17.5% | +48.1% | -4.6% | +16.6% | -38.5% | +15.7% | +14.1% | +13.8% | +22.4% | +10.0% | -1.2% | -0.9% | -46.5% | +0.1% | -42.1% | -6.7% | +104.6% | +1.3% | -27.4% | +49.5% | +5.5% | +46.3% | +8.8% | -48.0% | +58.4% | -34.0% | -59.8% | -0.7% | -85.2% | – | |
| – | +18.7% | +2.1% | +19.8% | +22.5% | -14.3% | +17.9% | +39.0% | -13.3% | +1.2% | +11.3% | +18.4% | +11.5% | +23.1% | +16.5% | +6.6% | +17.8% | -4.7% | -8.2% | +10.8% | +0.0% | +7.7% | -6.2% | -18.7% | -6.2% | +1.5% | -9.8% | -1.6% | +10.0% | -2.0% | -1.7% | +7.4% | +11.2% | – | |
| – | +12.6% | +2.1% | +39.1% | +12.8% | +31.1% | +10.8% | +159.1% | -53.6% | +5.9% | +1.1% | +40.1% | -4.6% | +9.7% | +6.2% | +12.9% | +13.0% | +2.5% | -6.9% | +20.6% | -20.9% | -13.9% | -1.3% | -3.7% | +0.7% | +3.2% | -4.4% | -2.4% | +9.8% | +15.6% | -8.1% | +8.1% | +27.0% | – | |
| – | +16.0% | +2.1% | +28.0% | +18.0% | +5.8% | +14.0% | +21.1% | -0.7% | +3.7% | +5.8% | +29.7% | +2.5% | +16.1% | +11.4% | +9.6% | +15.5% | -1.3% | -7.5% | +15.7% | +0.5% | -12.8% | +13.7% | -14.9% | -16.5% | +2.3% | -7.2% | -2.0% | +9.9% | +6.7% | -5.1% | +7.8% | +19.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.9% | -20.6% | -46.4% | -24.6% | +304.9% | -72.6% | +184.3% | -99.7% | +12,200.0% | -52.4% | -35.0% | +25.0% | -31.6% | -7.7% | -1.7% | +0.0% | -15.3% | -10.0% | +4.4% | +0.0% | -17.0% | -61.5% | -40.0% | +0.0% | +0.0% | -22.2% | -85.7% | +2,700.0% | +71.4% | +33.3% | +1.6% | -27.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -50.0% | +100.0% | +0.0% | +0.0% | +0.0% | -50.0% | +300.0% | +650.0% | -86.7% | +25.0% | +260.0% | -116.7% | – | +50.0% | -125.0% | – | +100.0% | -21.4% | -27.3% | +75.0% | +157.1% | -22.2% | -82.1% | +40.0% | -42.9% | -25.0% | +33.3% | +75.0% | -71.4% | +50.0% | +200.0% | +77.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.